Resultados de la búsqueda

Garcia-Gonzalez I, Gambera S, Rocha SF, Regano A, Garcia-Ortega L, Lytvyn M, Diago-Domingo L, Sanchez-Muñoz MS, Garcia-Cabero A, Zagorac I, Luo W, De Andrés-Laguillo M, Fernández-Chacón M, Casquero-Garcia V, Lunella FF, Torroja C, Sánchez-Cabo F, Benedito R. iFlpMosaics enable the multispectral barcoding and high-throughput comparative analysis of mutant and wild-type cells. Nat Methods (2024) 22:323-334
Link to the full text in Repisalud

Cerezo-Wallis D, Ballesteros I. The enduring neutrophil-stroma dance of multiple myeloma. Nat Immunol (2024) 25:731-732

Sánchez-Cabo F, Fuster V, Lara-Pezzi E. Inflammation contributes to the pathogenic effects of subclinical atherosclerosis. Eur Heart J (2024) 45:313
Link to the full text in Repisalud

Byrne R, Coughlan JJ, Rossello X, Ibanez B. The '10 commandments' for the 2023 ESC Guidelines for the management of acute coronary syndromes. Eur Heart J (2024) 45:1193-1195
Link to the full text in Repisalud

Zuriaga MA, Pascual-Figal D, Fuster JJ. Clonal haematopoiesis and cardiac arrythmias: rhythm-altering mutations. Eur Heart J (2024) 45:806-808
Link to the full text in Repisalud

Norata GD, Sancho D, Van den Bossche J, Ketelhuth DFJ. Understanding immunometabolism in cardiovascular disease: translating research into practice. Eur Heart J (2024) 45:2276-2278
Link to the full text in Repisalud

Domínguez F, Adler E, García-Pavía P. Alcoholic cardiomyopathy: an update. Eur Heart J (2024) 45:2294-2305
Link to the full text in Repisalud

Zuriaga MA, Yu Z, Matesanz N, Truong B, Ramos-Neble BL, Asensio-López MC, Uddin MM, Nakao T, Niroula A, Zorita V, Amorós-Pérez M, Moro R, Ebert BL, Honigberg MC, Pascual-Figal D, Natarajan P, Fuster JJ. Colchicine prevents accelerated atherosclerosis in TET2-mutant clonal haematopoiesis. 10.1093/eurheartj/ehae546. Eur Heart J (2024) 45:4601-4615
Link to the full text in Repisalud

Kresoja KP, Rubini Giménez M, Thiele H. The SEX-SHOCK score - The Emperor's New Clothes? Eur Heart J (2024) 45:4579-4581

Garcia-Pavia P, Oreziak A, Masri A, Barriales-Villa R, Abraham TP, Owens AT, Jensen MK, Wojakowski W, Seidler T, Hagege A, Lakdawala NK, Wang A, Wheeler MT, Choudhury L, Balaratnam G, Shah A, Fox S, Hegde SM, Olivotto I. Long-term effect of mavacamten in obstructive hypertrophic cardiomyopathy. Eur Heart J (2024) 45:5071-5083.